HBWM
CRL icon

Hollow Brook Wealth Management’s Charles River Laboratories CRL Stock Holding History

Hollow Brook Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
11,995
+11
+0.1% +$1.96K 0.54% 41
2026
Q1 		$2.07M Sell
11,984
-59
-0.5% -$10.9K 0.53% 43
2025
Q4 		$2.4M Sell
12,043
-1,330
-10% -$241K 0.62% 43
2025
Q3 		$2.09M Buy
13,373
+3,382
+34% +$537K 0.5% 48
2025
Q2 		$1.52M Buy
+9,991
New +$1.33M 0.44% 50

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Hollow Brook Wealth Management's CRL Position: Q2 2026 in Review

Hollow Brook Wealth Management increased its Charles River Laboratories (CRL) stake by 0.09% in Q2 2026, buying an estimated $1.96K and bringing the position to 11,995 shares worth $2.72M. The position accounts for 0.54% of the portfolio, ranked #41.

Hollow Brook Wealth Management first reported a position in CRL in Q2 2025 and has held it in 5 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Hollow Brook Wealth Management held 11,995 shares of Charles River Laboratories worth $2.72M as of Q2 2026.
  • Hollow Brook Wealth Management bought 11 Charles River Laboratories shares in Q2 2026, an estimated $1.96K.
  • Charles River Laboratories made up 0.54% of Hollow Brook Wealth Management's portfolio in Q2 2026, its #41 holding.
  • Hollow Brook Wealth Management first reported a position in Charles River Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Hollow Brook Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.